Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridioides difficile cell-surface antigens and lysate components comprise a diverse array of molecular targets found on the surface and within the vegetative cells and spores of the bacterium Clostridioides difficile. These targets include surface-layer proteins (SLPs), cell wall proteins (Cwps), flagellar components, and various intracellular proteins released during cell lysis, alongside the critical virulence factor Toxin B (TcdB). Biologically, these components are vital for the bacterium's lifecycle, facilitating adherence to the intestinal mucosa, colonization of the gut, and the initiation of inflammatory processes through toxin secretion. In clinical settings, C. difficile is the primary cause of antibiotic-associated diarrhea and can lead to severe conditions such as pseudomembranous colitis and toxic megacolon. Therapeutic interventions, such as the oral polyclonal antibody IMM-529, are designed to target this broad spectrum of antigens to neutralize toxins and inhibit bacterial colonization. By addressing multiple stages of the infection cycle, these therapies aim to treat active disease and prevent the high rates of recurrence characteristic of C. difficile infections while sparing the host's beneficial gut microbiota.
Polyclonal antibody-mediated neutralization of toxins (specifically Toxin B), inhibition of bacterial adhesion to intestinal epithelium, and prevention of spore-mediated colonization and germination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridioides difficile cell-surface antigens and lysate components.